Suppr超能文献

尪痹片治疗类风湿关节炎和膝骨关节炎临床应用专家共识

[Expert consensus on clinical application of Wangbi Tablets in treating rheumatoid arthritis and knee osteoarthritis].

作者信息

Chen Wei-Heng, Weng Xi-Sheng, Yan Xiao-Ping, Liu Wei, Jin Ying-Hui, Lin Na, Zhao Yan

机构信息

Third Affiliated Hospital, Beijing University of Chinese Medicine Beijing 100029, China.

Peking Union Medical College Hospital Beijing 100730, China.

出版信息

Zhongguo Zhong Yao Za Zhi. 2021 Sep;46(17):4569-4574. doi: 10.19540/j.cnki.cjcmm.20210125.501.

Abstract

Wangbi Tablets are widely used in the treatment of rheumatoid arthritis, knee osteoarthritis and other diseases at pre-sent. Long-term clinical application and research have shown that this drug has a good effect in reducing the pain of related diseases and improving symptoms. Due to the lack of guidance in the instructions and currently no relevant norms to guide the clinical application of Wangbi Tablets, in order to further improve clinicians' understanding of the drug and fully tap the clinical advantages of the drug, the Professional Committee of Orthopedics and Traumatology Drug Research of China Association of Chinese Medicine organized experts in the fields of rheumatism, orthopedics, pharmacy and methodology in Chinese and western medicine to develop expert consensus on Chinese patent medicines in accordance with the relevant requirements of the consensus methodology. Based on full consideration of clinical research evidence and expert experience, the clinical issues were summarized in the consensus, and for those clinical problems supported by evidences, the internationally recognized recommendation evaluation and formulation method GRADE was used to evaluate the evidence and form recommendations; for those clinical issues not supported by evidences, a consensus was reached through the nominal group method to form consensus recommendations. The consensus adopted a concise and clear format to form re-commendations or reach consensus suggestions on the medication regimen, medication characteristics, intervention timing, usage and dosage, course of use and safety issues for the treatment of rheumatoid arthritis and knee osteoarthritis with Wangbi Tablets. It is suggested that its application will better improve the efficacy of Wangbi Tablets in the treatment of rheumatoid arthritis and knee osteoarthritis, at the same time provide a reference for clinicians to use Wangbi Tablets in a standardized, reasonable and safe manner.

摘要

尪痹片目前广泛应用于类风湿关节炎、膝关节骨关节炎等疾病的治疗。长期临床应用与研究表明,该药物在减轻相关疾病疼痛、改善症状方面效果良好。由于说明书缺乏指导且目前尚无相关规范指导尪痹片的临床应用,为进一步提高临床医生对该药物的认识,充分挖掘其临床优势,中华中医药学会骨伤科药物研究专业委员会组织中西医风湿、骨伤、药学及方法学等领域专家,按照共识方法学的相关要求制定中成药专家共识。在充分考虑临床研究证据和专家经验的基础上,在共识中总结临床问题,对于有证据支持的临床问题,采用国际认可的推荐评估与制定方法GRADE对证据进行评估并形成推荐;对于无证据支持的临床问题,通过名义组法达成共识形成共识性推荐。该共识采用简洁明了的格式,对尪痹片治疗类风湿关节炎和膝关节骨关节炎的用药方案、用药特点、干预时机、用法用量、疗程及安全性问题等形成推荐或达成共识性建议。建议其应用将更好地提高尪痹片治疗类风湿关节炎和膝关节骨关节炎的疗效,同时为临床医生规范、合理、安全使用尪痹片提供参考。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验